Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03984396 · ClinicalTrials.gov registry record · NA
Optimal Medication Management in Alzheimer's Disease and Dementia
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 7,398
- Enrollment target
NCT03984396 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 7,398 participants.
The verdict
NCT03984396, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,398 participants
- Enrollment target
Study Summary
The study objective is to conduct a pragmatic deprescribing intervention for people with Alzheimer's Disease or Related Dementia with Multiple Chronic Conditions (ADRD-MCC) so that these patients are on 'just right' medication regimens. The intervention will be a pragmatic, cluster randomized trial of medication optimization through increased awareness of deprescribing for the ADRD-MCC population. It will be delivered in primary care at the clinic level with a wait-list control design. As a pragmatic intervention it is designed to be relatively simple, have broad inclusion/exclusion criteria, and be implemented across the Kaiser Permanente Colorado (KPCO) system. The intervention will have two components: a patient/care partner component focused on education and activation about potential deprescribing including sending out a brochure, and a clinician component focused on increasing clinician awareness through monthly Tip Sheets about options and processes for deprescribing in the ADRD-MCC population linked to upcoming visits. The intervention will take place at 18 primary care offices in the Denver-Boulder service delivery area with 9 as initial intervention sites and 9 as delayed intervention sites.
Interventions
- OTHER Educational Materials - Patient & Clinician
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,398 participants |
| Start Date | 2019-03-06 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03984396
The ClinicalTrials.gov registry entry for NCT03984396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,398 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Educational Materials - Patient & Clinician is the first listed.
NCT03984396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03984396 about?
NCT03984396 is a clinical study titled "Optimal Medication Management in Alzheimer's Disease and Dementia". The study objective is to conduct a pragmatic deprescribing intervention for people with Alzheimer's Disease or Related Dementia with Multiple Chronic Conditions (ADRD-MCC) so that these patients are on 'just right' medication regimens. The intervention will be a pragmatic, cluster randomized trial...
What is the current status of trial NCT03984396?
This trial is currently completed. It is a NA study. The enrollment target is 7,398 participants. The study started on 2019-03-06. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT03984396?
The interventions under investigation include: Educational Materials - Patient & Clinician (OTHER).
Who is sponsoring clinical trial NCT03984396?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.